Kuchulakanti, Pramod K <br/><br/>
Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.  [electronic resource] 

 -  The American journal of cardiology  Jul 2006 
 - 187-92 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/j.amjcard.2006.01.074  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Blood Vessel Prosthesis Implantation--instrumentation<br/>Coated Materials, Biocompatible<br/>Coronary Angiography<br/>Coronary Disease--complications<br/>Diabetes Mellitus, Type 1--complications<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Male<br/>Middle Aged<br/>Paclitaxel--pharmacology<br/>Prospective Studies<br/>Sirolimus--pharmacology<br/>Stents<br/>Treatment Outcome